# Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin

> **NCT00802139** · PHASE4 · COMPLETED · sponsor: **JW Pharmaceutical** · enrollment: 58 (actual)

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** venoferrum(iron sucrose)
- **DRUG:** Bolgre (Iron acetyl-transferase)

## Key facts

- **NCT ID:** NCT00802139
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-06
- **Final completion:** 2010-10
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2012-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00802139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00802139, "Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00802139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*